Terazocin 2mg and 5mg per tablet
Use in benign Prostatic Hyperplasia:
Studies suggest that alpha-1-adrenoreceptor antagonism is useful in improving the urodynamics in patients with chronic obstruction such as in benign prostatic hyperplasia (BPH).
Use in hypertension:
Although the exact mechanism of the hypotensive action is not established, the relaxation of peripheral blood vessels appears to be produced mainly by competitive antagonism of post-synaptic alpha-1-adrenoceptor. Terazosin usually produces an initial gradual decrease in blood pressure followed by a sustained anti hypertensive action.
Terazosin tablets are indicated for:
• the treatment of mild to moderate hypertension
• symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia (BPH).
For oral use.
For the different dosage regimens suitable strengths are available.
The dose of terazosin should be adjusted according to the patient’s response.